Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(25%)
Results Posted
17%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting3
Suspended1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (9.1%)
N/A10 (90.9%)

Trials by Status

recruiting325%
suspended18%
terminated18%
completed650%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
12